Literature DB >> 9375213

The nature of learning and memory impairments in schizophrenia.

J S Paulsen1, R K Heaton, J R Sadek, W Perry, D C Delis, D Braff, J Kuck, S Zisook, D V Jeste.   

Abstract

The California Verbal Learning Test was used to characterize the learning and memory impairment in schizophrenia (SC) and to evaluate potential clinical and demographic factors associated with this impairment. SC patients (n = 175) performed worse than normal comparison (NC) subjects (n = 229) on all learning, recall, and recognition memory measures. The most important clinical correlates of these impairments were earlier age of onset, more negative symptoms, and greater anticholinergic medication dosage. SC patients showed a prominent retrieval deficit as indicated by disproportionate improvement when tested in a recognition, rather than a free recall, format. A residual impairment seen with recognition testing suggests a mild encoding deficit as well. In contrast, the relative absence of a storage deficit is suggested by the lack of rapid forgetting. Using a discriminant function analysis that differentiates cortical dementia [i.e., Alzheimer's disease (AD)], subcortical dementia [i.e., Huntington's disease (HD)], and normals, it was found that 50% of the SC patients were classified as having a subcortical memory profile and 35% were classified as having a normal profile, whereas only 15% were classified as having a cortical memory profile. Although these findings reflect the clinical heterogeneity often found in SC, results suggest that most SC patients demonstrate a pattern of learning and memory impairments that resembles the pattern seen in patients with primary subcortical (specifically striatal) pathology.

Entities:  

Mesh:

Year:  1995        PMID: 9375213     DOI: 10.1017/s135561770000014x

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  50 in total

Review 1.  Sources of heterogeneity in schizophrenia: the role of neuropsychological functioning.

Authors:  B E Seaton; G Goldstein; D N Allen
Journal:  Neuropsychol Rev       Date:  2001-03       Impact factor: 7.444

Review 2.  Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience.

Authors:  Sandra S Kindermann; Christian R Dolder; Anne Bailey; Ira R Katz; Dilip V Jeste
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 3.  Profiles of neuropsychologic function in schizophrenia.

Authors:  J Daniel Ragland
Journal:  Curr Psychiatry Rep       Date:  2003-08       Impact factor: 5.285

Review 4.  The California Verbal Learning Test: psychometric characteristics and clinical application.

Authors:  R W Elwood
Journal:  Neuropsychol Rev       Date:  1995-09       Impact factor: 7.444

5.  Effect of schizophrenia on frontotemporal activity during word encoding and recognition: a PET cerebral blood flow study.

Authors:  J D Ragland; R C Gur; J Raz; L Schroeder; C G Kohler; R J Smith; A Alavi; R E Gur
Journal:  Am J Psychiatry       Date:  2001-07       Impact factor: 18.112

Review 6.  Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function.

Authors:  William S Stone; Larry J Seidman
Journal:  Schizophr Bull       Date:  2007-05-15       Impact factor: 9.306

7.  Functional magnetic resonance imaging of internal source monitoring in schizophrenia: recognition with and without recollection.

Authors:  J Daniel Ragland; Jeffrey N Valdez; James Loughead; Ruben C Gur; Raquel E Gur
Journal:  Schizophr Res       Date:  2006-06-30       Impact factor: 4.939

8.  Is late-onset schizophrenia a subtype of schizophrenia?

Authors:  I V Vahia; B W Palmer; C Depp; I Fellows; S Golshan; H C Kraemer; Dilip V Jeste
Journal:  Acta Psychiatr Scand       Date:  2010-11       Impact factor: 6.392

9.  Memory profiles in schizophrenia: categorization validity and stability.

Authors:  Morris D Bell; Jason K Johannesen; Tamasine C Greig; Bruce E Wexler
Journal:  Schizophr Res       Date:  2010-01-20       Impact factor: 4.939

10.  Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia.

Authors:  S Kristian Hill; John A Sweeney; Robert M Hamer; Richard S E Keefe; Diana O Perkins; Hongbin Gu; Joseph P McEvoy; Jeffrey A Lieberman
Journal:  J Int Neuropsychol Soc       Date:  2008-03       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.